Cargando…

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward

Detalles Bibliográficos
Autores principales:	Le Joncour, Alexandre, Frere, Corinne, Martin-Toutain, Isabelle, Gougis, Paul, Ghillani-Dalbin, Pascale, Maalouf, Georgina, Vieira, Matheus, Marcelin, Anne-Geneviève, Salem, Joe-Elie, Allenbach, Yves, Saadoun, David, Benveniste, Olivier, Cacoub, Patrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834187/ https://www.ncbi.nlm.nih.gov/pubmed/33321245 http://dx.doi.org/10.1016/j.autrev.2020.102729

Ejemplares similares

Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2
por: Fenioux, Charlotte, et al.
Publicado: (2021)

Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191–93
por: Vieira, Matheus, et al.
Publicado: (2021)

Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients
por: Allenbach, Yves, et al.
Publicado: (2020)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19
por: Salem, Joe-Elie, et al.
Publicado: (2022)

Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature
por: Kai, Martine, et al.
Publicado: (2023)

Biotherapies in Uveitis
por: Leclercq, Mathilde, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021)

Thrombophilia Associated with Anti-DFS70 Autoantibodies
por: Marlet, Julien, et al.
Publicado: (2015)

Management of Antiphospholipid Syndrome
por: Ghembaza, Amine, et al.
Publicado: (2020)

Clinical Management of Thrombotic Antiphospholipid Syndrome
por: Tumian, Nor Rafeah, et al.
Publicado: (2022)

Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis
por: Boleto, Gonçalo, et al.
Publicado: (2020)

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
por: Anunciación-Llunell, Ariadna, et al.
Publicado: (2022)

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals
por: Comarmond, Cloé, et al.
Publicado: (2020)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease
por: Grados, Aurélie, et al.
Publicado: (2013)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016)

Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients
por: Phan, Franck, et al.
Publicado: (2021)

Catastrophic antiphospholipid antibody syndrome in a child with thrombotic microangiopathy
por: Prasad, N., et al.
Publicado: (2012)

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome
por: Sirinvaravong, Natee, et al.
Publicado: (2018)

Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management
por: Sayar, Zara, et al.
Publicado: (2021)

Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
por: Dolin, Hallie Hanna, et al.
Publicado: (2019)

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
por: Sayar, Zara, et al.
Publicado: (2022)

Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients
por: Kansuttiviwat, Chalermkiat, et al.
Publicado: (2023)

Recurrent Nonbacterial Thrombotic Endocarditis and Primary Antiphospholipid Antibody Syndrome
por: Mandal, Amit K, et al.
Publicado: (2023)

PReS-FINAL-2349: Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2013)

Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients
por: Le Joncour, Alexandre, et al.
Publicado: (2018)

Catastrophic Antiphospholipid Syndrome with Severe Acute Thrombotic Microangiopathy and Hemorrhagic Complications
por: Vieregge, Gerardo B., et al.
Publicado: (2013)

Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity
por: Pyo, Jung Yoon, et al.
Publicado: (2017)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022)

Evaluation of a gene signature related to thrombotic manifestations in antiphospholipid syndrome
por: Jacintho, Bruna Cardoso, et al.
Publicado: (2023)

Antiphospholipid Syndrome Nephropathy with Acute Thrombotic Microangiopathy after Renal Transplantation
por: Suenaga, Atsuhiko, et al.
Publicado: (2023)

Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study
por: Su, Zhenzhen, et al.
Publicado: (2022)

Detection in whole blood of autoantibodies for the diagnosis of connective tissue diseases in near patient testing condition
por: Miyara, Makoto, et al.
Publicado: (2018)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome
por: Velásquez, Manuela, et al.
Publicado: (2021)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2015)

Nonbacterial Thrombotic Endocarditis of the Tricuspid Valve in a Male Patient with Antiphospholipid Syndrome
por: Yordan-Lopez, Nicole M, et al.
Publicado: (2018)

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
por: Siguret, Virginie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i0c4n6750qos7bg6p40n98ct6f